United States

ENDO 2022

Novel Non Statin Therapies for LDL Cholesterol Lowering - Bempedoic acid - current evidence: Does it live up to the hype?

**Program**
ENDO’s comprehensive program provides attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world. 

This year’s education program features:
more than 100 in-person and virtual sessions with another 70+ in-person only sessions;
six plenary sessions including plenaries on Envisioning Future Therapies for Type 1 Diabetes and Addressing Challenges in Fertility and Reproduction;
over 20 Meet the Professor sessions presented both in-person and live-streamed virtually and another 20+ presented live in Atlanta;
four Basic Science Pathways, including Diabetes and Metabolism; Neuroendocrinology; Nuclear Receptors and Signaling; and Reproductive Endocrinology; and
more than 30 oral sessions and a robust virtual poster hall for accepted scientific abstracts.

**What Programming Is Included in My Virtual Meeting Registration?**
As you build your schedule during the conference, you can select the sessions that are tagged with 'Livestreamed', so you can view virtually. These sessions are being livestreamed, so they are available in real time to our virtual audience. In addition, our in-person and livestreamed sessions will be recorded, so you can access them on demand after 72 hours. We will have over 200 hours available on demand for Standard and Premium pass registrants.

Product theaters and the Communications and Career Center will also include hybrid content delivery.

**Plenaries**
Spanning the spectrum of science, clinical care, and social implications, an outstanding slate of world-renowned speakers will showcase the most cutting-edge advances on research and medicine.

**Symposia**
Our ENDO 2022 lineup of sessions offers a unique opportunity to dive into topics from nearly every major therapeutic area of endocrinology and hormone science. Listen, learn, and be inspired by world-class faculty who are at the forefront of scientific discovery and high-quality health care.

**Basic Science Pathways**

These special “meeting-within-a-meeting” tracks integrate focused discussions, poster sessions, and networking opportunities to provide you with the latest research in:
Diabetes and Metabolism
Neuroendocrinology
Nuclear Receptors and Signaling
Reproductive Endocrinology

**Meet the Professor & Meet the Scientist**
Discover insights from experts on treating a variety of endocrine conditions and emerging science in the field of endocrinology, and learn the latest in patient care and scientific research.

ENDO’s comprehensive program provides attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world. 

technical paper

Novel Non Statin Therapies for LDL Cholesterol Lowering - PCSK9 inhibitors - cardiovascular outcome data

Novel Non Statin Therapies for LDL Cholesterol Lowering - Angiopoetin like-3 inhibitor - the new kid on the block

Dealing With Growing Pains - New Insights into Childhood Growth from Genome-Wide Approaches

Dealing With Growing Pains - Epigenetic regulation of the growth plate

Exploring New Diagnostic and Treatment Options for Fatty Liver Disease From Pediatrics to Adult Care - NAFLD and What’s In Development Today

Exploring New Diagnostic and Treatment Options for Fatty Liver Disease From Pediatrics to Adult Care - Pediatric NAFLD: are there any treatments?

Exploring New Diagnostic and Treatment Options for Fatty Liver Disease From Pediatrics to Adult Care - Proven weight loss strategies in NAFLD

Cellular Confusion – A Consequence of Endocrine Disruption During Development

Early life chemical exposure and epigenetic reprogramming of metabolism

Transgenerational epigenetic changes driving PCOS

https://d3smihljt9218e.cloudfront.net/transcript/43361/subtitle/7939746a59f4339013373d67c3fe45f2.vtt

English (automatic)

Novel Non Statin Therapies for LDL Cholesterol Lowering - Bempedoic acid - current evidence: Does it live up to the hype?

Downloads

Next from ENDO 2022

Novel Non Statin Therapies for LDL Cholesterol Lowering - PCSK9 inhibitors - cardiovascular outcome data

Similar lecture

Targeting Hyperglucagonemia Reverses Glucagon Resistance

Stay up to date with the latest Underline news!

PRESENTATIONS

CONFERENCES

COMPANY

RESOURCES